What is the success rate of hiatal hernia repair in adults with typical symptoms such as gastroesophageal reflux disease (GERD) symptoms, chest pain, or difficulty swallowing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hiatal Hernia Repair Success Rates

Laparoscopic hiatal hernia repair achieves excellent symptomatic relief with 83-85% of patients reporting good to excellent results, though anatomic recurrence rates range from 20-34% at long-term follow-up, with most recurrences being asymptomatic and not requiring reoperation. 1, 2

Symptomatic Success Rates

  • The majority of patients (83-85%) report good to excellent outcomes after laparoscopic hiatal hernia repair, with significant improvement in heartburn, dysphagia, and retrosternal pain 1, 2
  • Patient satisfaction is high, with 85% stating they would undergo the operation again if necessary 2
  • 80-92% of patients report improvement in overall quality of life after surgery 2, 3

The Society of American Gastrointestinal and Endoscopic Surgeons recommends laparoscopic fundoplication with crural repair as the primary surgical option for hiatal hernia with severe GERD, which forms the basis for these outcomes 4

Anatomic Recurrence Rates

  • Radiologic recurrence rates range from 20-34% at medium to long-term follow-up (5-10 years) 1, 5, 6
  • The anatomic recurrence rate is 24.3% at mean 39-month follow-up, regardless of mesh use 6
  • At 10-year follow-up, 34% of patients demonstrate anatomic recurrence on barium swallow 1

Critical caveat: Anatomic recurrence does not equal clinical failure. Most radiologic recurrences are asymptomatic and do not require intervention 1, 3

Symptomatic Recurrence and Reoperation Rates

  • Symptomatic recurrence occurs in only 13-21% of patients, which is substantially lower than anatomic recurrence 5, 6
  • Reoperation rates are low at 7-15%, even with documented anatomic recurrence 2, 6
  • At 2-year follow-up, only 5.4% had anatomic recurrence requiring surgical revision 3

Quality of Life Outcomes

  • GERD-HRQL scores significantly decrease postoperatively (p < 0.001), indicating marked symptom improvement 3
  • SF-36 Physical and Mental Component Summary scores significantly improve with medium effect sizes (-0.77 and 0.56 respectively) 3
  • Patients with asymptomatic anatomic recurrence maintain quality of life scores comparable to those without recurrence 1, 5
  • Patients with symptomatic recurrence have significantly lower GIQLI scores than asymptomatic patients, highlighting that symptoms—not anatomy—drive quality of life 5

Medication Reduction

  • PPI use decreases from 86.4% preoperatively to 13.5% at 2-year follow-up (p < 0.001) 3
  • Use of antidepressants and benzodiazepines significantly decreases from 32.4% to 8.1% postoperatively (p < 0.001), suggesting improvement in psychological comorbidities related to chronic GERD 3

Safety Profile

The American Gastroenterological Association recommends surgical repair for confirmed pathologic GERD with inadequate response to optimized medical therapy, based on the established safety profile 7

  • Intraoperative complication rate is 1.8% 2
  • Postoperative morbidity ranges from 14.5% 2
  • Mortality is very low at 1.8% 2
  • The Society of American Gastrointestinal and Endoscopic Surgeons reports an overall in-hospital mortality rate of 0.14% for laparoscopic approach 8
  • No serious mesh-related complications were reported in studies using non-absorbable mesh 3, 6

Mesh vs. No Mesh Outcomes

  • Radiologic recurrence rates are equal whether mesh is used (25.8%) or not (23.6%), P = 0.331 6
  • Symptomatic recurrence and reoperation rates are comparable between mesh (16.1% and 9.7%) and no-mesh groups (11.8% and 6.3%) 6
  • Quality of life, dysphagia, and patient satisfaction are equivalent regardless of mesh use 6

The evidence does not support routine mesh use, as it provides no advantage in preventing symptomatic recurrence or improving patient-reported outcomes 6

Specific Symptom Resolution

  • Postoperative heartburn significantly improves (p < 0.001) 2
  • Retrosternal/epigastric pain significantly improves (p = 0.028) 2
  • Dysphagia improvement is variable and not always statistically significant (p = 0.8), though the Society of American Gastrointestinal and Endoscopic Surgeons notes that Toupet fundoplication (270° wrap) has potentially lower rates of postoperative dysphagia compared to Nissen 8
  • Overall alimentary satisfaction scores exceed 8/10 in 92% of patients 3

Long-Term Durability

  • Effective and durable symptom relief is maintained at mean 114-month (9.5-year) follow-up 1
  • Follow-up ranging from 72 to 185 months demonstrates sustained benefit in the majority of patients 1
  • At 2-year follow-up, symptoms had disappeared in the majority of patients 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.